vs

Side-by-side financial comparison of SAGA COMMUNICATIONS INC (SGA) and Xilio Therapeutics, Inc. (XLO). Click either name above to swap in a different company.

SAGA COMMUNICATIONS INC is the larger business by last-quarter revenue ($26.5M vs $13.7M, roughly 1.9× Xilio Therapeutics, Inc.). Xilio Therapeutics, Inc. runs the higher net margin — 75.7% vs -26.1%, a 101.8% gap on every dollar of revenue. SAGA COMMUNICATIONS INC produced more free cash flow last quarter ($-459.0K vs $-2.1M).

Saga is a British company focused on serving the needs of those aged 50 and over, originally owned by its founder, later acquired by private equity, and ultimately listed on the London Stock Exchange. It has 2.7 million customers. The company operates sites on the Kent and Sussex coast: Enbrook Park and Priory Square. It is listed on the London Stock Exchange and is a constituent of the FTSE 250 Index.

Xilio Therapeutics is a clinical-stage biotechnology company dedicated to developing novel tumor-selective immunotherapies for cancer treatment. Its product pipeline features candidates engineered to trigger anti-tumor immune responses specifically inside tumor microenvironments, reducing systemic toxicities, and it primarily targets oncology patient populations in North America and other global markets.

SGA vs XLO — Head-to-Head

Bigger by revenue
SGA
SGA
1.9× larger
SGA
$26.5M
$13.7M
XLO
Higher net margin
XLO
XLO
101.8% more per $
XLO
75.7%
-26.1%
SGA
More free cash flow
SGA
SGA
$1.6M more FCF
SGA
$-459.0K
$-2.1M
XLO

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
SGA
SGA
XLO
XLO
Revenue
$26.5M
$13.7M
Net Profit
$-6.9M
$10.4M
Gross Margin
Operating Margin
-36.0%
-86.5%
Net Margin
-26.1%
75.7%
Revenue YoY
-9.3%
Net Profit YoY
-645.3%
179.1%
EPS (diluted)
$-1.07
$-3.74

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
SGA
SGA
XLO
XLO
Q4 25
$26.5M
$13.7M
Q3 25
$28.2M
$19.1M
Q2 25
$28.2M
$8.1M
Q1 25
$24.2M
$2.9M
Q4 24
$29.2M
Q3 24
$28.7M
Q2 24
$29.7M
Q1 24
$25.3M
Net Profit
SGA
SGA
XLO
XLO
Q4 25
$-6.9M
$10.4M
Q3 25
$-532.0K
$-16.3M
Q2 25
$1.1M
$-15.8M
Q1 25
$-1.6M
$-13.3M
Q4 24
$1.3M
Q3 24
$1.3M
Q2 24
$2.5M
Q1 24
$-1.6M
Operating Margin
SGA
SGA
XLO
XLO
Q4 25
-36.0%
-86.5%
Q3 25
-2.2%
-10.1%
Q2 25
5.0%
-177.7%
Q1 25
-9.5%
-472.7%
Q4 24
3.4%
Q3 24
5.7%
Q2 24
7.2%
Q1 24
-9.6%
Net Margin
SGA
SGA
XLO
XLO
Q4 25
-26.1%
75.7%
Q3 25
-1.9%
-85.4%
Q2 25
4.0%
-196.0%
Q1 25
-6.5%
-452.7%
Q4 24
4.3%
Q3 24
4.4%
Q2 24
8.4%
Q1 24
-6.2%
EPS (diluted)
SGA
SGA
XLO
XLO
Q4 25
$-1.07
$-3.74
Q3 25
$-0.08
$-0.11
Q2 25
$0.18
$-0.16
Q1 25
$-0.25
$-0.18
Q4 24
$0.20
Q3 24
$0.20
Q2 24
$0.40
Q1 24
$-0.25

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
SGA
SGA
XLO
XLO
Cash + ST InvestmentsLiquidity on hand
$31.8M
$137.5M
Total DebtLower is stronger
$5.0M
Stockholders' EquityBook value
$151.5M
$35.3M
Total Assets
$201.3M
$154.7M
Debt / EquityLower = less leverage
0.03×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
SGA
SGA
XLO
XLO
Q4 25
$31.8M
$137.5M
Q3 25
$26.3M
$103.8M
Q2 25
$24.9M
$121.6M
Q1 25
$27.0M
$89.1M
Q4 24
$27.8M
Q3 24
$28.7M
Q2 24
$24.1M
Q1 24
$28.8M
Total Debt
SGA
SGA
XLO
XLO
Q4 25
$5.0M
Q3 25
$5.0M
Q2 25
$5.0M
Q1 25
$5.0M
Q4 24
$5.0M
Q3 24
$5.0M
Q2 24
$5.0M
Q1 24
$0
Stockholders' Equity
SGA
SGA
XLO
XLO
Q4 25
$151.5M
$35.3M
Q3 25
$162.1M
$-8.1M
Q2 25
$163.7M
$7.1M
Q1 25
$163.6M
$10.7M
Q4 24
$165.9M
Q3 24
$166.0M
Q2 24
$165.8M
Q1 24
$164.4M
Total Assets
SGA
SGA
XLO
XLO
Q4 25
$201.3M
$154.7M
Q3 25
$218.4M
$133.7M
Q2 25
$218.9M
$133.8M
Q1 25
$219.3M
$103.7M
Q4 24
$221.7M
Q3 24
$223.2M
Q2 24
$221.6M
Q1 24
$218.0M
Debt / Equity
SGA
SGA
XLO
XLO
Q4 25
0.03×
Q3 25
0.03×
Q2 25
0.03×
Q1 25
0.03×
Q4 24
0.03×
Q3 24
0.03×
Q2 24
0.03×
Q1 24
0.00×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
SGA
SGA
XLO
XLO
Operating Cash FlowLast quarter
$-18.0K
$-2.0M
Free Cash FlowOCF − Capex
$-459.0K
$-2.1M
FCF MarginFCF / Revenue
-1.7%
-15.3%
Capex IntensityCapex / Revenue
1.7%
0.7%
Cash ConversionOCF / Net Profit
-0.19×
TTM Free Cash FlowTrailing 4 quarters
$2.4M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
SGA
SGA
XLO
XLO
Q4 25
$-18.0K
$-2.0M
Q3 25
$3.4M
$-17.5M
Q2 25
$755.0K
$-14.5M
Q1 25
$1.4M
$29.0M
Q4 24
$3.6M
Q3 24
$5.1M
Q2 24
$1.2M
Q1 24
$3.8M
Free Cash Flow
SGA
SGA
XLO
XLO
Q4 25
$-459.0K
$-2.1M
Q3 25
$2.8M
Q2 25
$-559.0K
$-14.9M
Q1 25
$668.0K
$29.0M
Q4 24
$3.1M
Q3 24
$4.5M
Q2 24
$-280.0K
Q1 24
$2.8M
FCF Margin
SGA
SGA
XLO
XLO
Q4 25
-1.7%
-15.3%
Q3 25
9.8%
Q2 25
-2.0%
-184.0%
Q1 25
2.8%
988.3%
Q4 24
10.5%
Q3 24
15.6%
Q2 24
-0.9%
Q1 24
10.9%
Capex Intensity
SGA
SGA
XLO
XLO
Q4 25
1.7%
0.7%
Q3 25
2.1%
0.0%
Q2 25
4.7%
5.0%
Q1 25
2.9%
0.8%
Q4 24
1.9%
Q3 24
2.2%
Q2 24
5.1%
Q1 24
4.2%
Cash Conversion
SGA
SGA
XLO
XLO
Q4 25
-0.19×
Q3 25
Q2 25
0.67×
Q1 25
Q4 24
2.86×
Q3 24
4.02×
Q2 24
0.50×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

SGA
SGA

Broadcast Advertising Revenue Net$20.2M76%
Digital Advertising Revenue$4.3M16%
Other Revenue$1.9M7%

XLO
XLO

Segment breakdown not available.

Related Comparisons